NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed ” or the “Company ”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
PARIS--(BUSINESS WIRE)--Regulatory News: The holders of the 2028 Notes 1 and the 2031 Notes 2 issued by Verallia (Paris:VRLA) have been informed through a notice published on 1 August 2025 (the “Put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results